Are We Prepared To Manage Anticoagulated ICH Patients or Should We Direct Them Elsewhere?

June 28, 2022
How and where to treat ICH patients- politics, reversal agents, and science all in one podcast!
1 Comments

AI in Imaging - We All Know It’s Coming. Are We Ready for the Machines in Stroke?

June 21, 2022
AI is coming but are we ready for it in stroke imaging?
0 Comments

Telemedicine and Stroke: What Have We Done?

June 14, 2022
Is telemedicine the savior for stroke care or the start part of the downfall of acute medicine?
0 Comments

Stroke Center Designations Are Big Business. Are They More Than That for Patient Care?

June 7, 2022
Stroke center designations are the currency of the realm; but does it matter to patients?
0 Comments

Telemedicine and Acute Stroke Research: What Is the State of the Union?

May 24, 2022

Telemedicine is the future of stroke - is it the future of stroke research?

0 Comments
RSS
245678910Last
Categories
More Entries

Dec 4

What Was Missing From the NINDS Trial?

Brian Gibler posted on 12/4/2020

Moderator: Jordan Bonomo, MD, FCCM, FNCS
Other Participants: Opeolu Adeoye, MD, MS FACEP, FAHA

The NINDS trial was the seminal study of IV-tPA in the treatment of acute stroke. Yet controversy still exists around the trial methodology and the interpretation of the data. Was anything missing from NINDS? Does it still resonate nearly 25 years later?

Dr. Opeolu (Ope) Adeoye sits down with Dr. Jordan Bonomo and shares his immense expertise in clinical trialing. As a researcher carrying over $30M in research funding, Dr. Adeoye is an internationally recognized stroke trialist and methodologist. In this podcast, he talks about the challenges of the NINDS trial, what was really well done and what could have been different. “Time critical diagnosis” is the term he wields in this exciting and thought provoking podcast.

0 Comments
Please login or register to post comments.